When Grant Decisions Meet Politics: What happened with NIH funding

The White House is drafting an executive order that would place many National Institutes of Health grant awards under additional review. President Donald Trump directed Russ Vought, director of the Office of Management and Budget, to prepare a proposal for a board that would include the NIH director, Jay Bhattacharya, and other senior officials and that would require unanimous decisions on which grants move forward. The reported structure would insert a political oversight layer above traditional scientific peer review.

This effort follows earlier White House steps to change grant oversight; a 2025 White House action outlined broad aims to improve federal grantmaking and agency oversight. Meanwhile, Nature has reported that more than 100 advisory panels have been closed or are losing members, and NIH posted notices this year about emergency modifications to peer review schedules. Plaintiffs in a recent court filing say NIH screening used a list of 235 keywords to flag applications.

Researchers and legal groups have filed a class-action lawsuit that challenges the screening practices and says the added reviews censor certain topics. The lawsuit and public concern reflect real effects: investigators report delays and some terminated projects, while agencies try to balance oversight with timely funding. If the new board gains authority, program decisions that normally rest with institute staff could shift toward political appointees.

Debate now centers on how to protect scientific standards while ensuring accountable spending; the outcome is likely to affect many laboratories and grant recipients nationwide.